TrialJournal of the American Society of Nephrology : JASN2020

A Randomized Trial of Empagliflozin to Increase Plasma Sodium Levels in Patients with the Syndrome of Inappropriate Antidiuresis.

Julie Refardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.